(Q44411708)

2 December 2017

title

Ultraviolet index and racial differences in prostate cancer incidence and mortality (English)

1 reference

2 December 2017

1

1 reference

2 December 2017

Edward L. Giovannucci

series ordinal

3

object named as

Edward Giovannucci

1 reference

2 December 2017

5

Nancy L Keating

1 reference

2 December 2017

David M Cutler

2

1 reference

2 December 2017

Matthew R Smith

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

6 June 2013

1 reference

2 December 2017

1 reference

2 December 2017

volume

119

1 reference

2 December 2017

issue

17

1 reference

2 December 2017

page(s)

3195-3203

1 reference

2 December 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

The Vitamin D and Cancer Conundrum: Aiming at a Moving Target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Prospective study of serum vitamin D and cancer mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

The role of vitamin D in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Vitamin D: A millenium perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Prostate cancer survival is dependent on season of diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Serum vitamin D concentration and prostate cancer risk: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Increased skin pigment reduces the capacity of skin to synthesise vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Estimated equivalency of vitamin D production from natural sun exposure versus oral vitamin D supplementation across seasons at two US latitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Association between plasma 25-OH vitamin D and testosterone levels in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

Vitamin D and cancer: current dilemmas and future research needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

7 January 2021

Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

7 January 2021

Pharmacokinetics of vitamin D toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

7 January 2021

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

7 January 2021

Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28127

7 January 2021

Identifiers

DOI

10.1002/CNCR.28127

1 reference

2 December 2017

1 reference